IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients

IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients

Abstract Background The ability of generating effective humoral immune responses to SARS-CoV-2 infection has not been clarified in lymphoma patients. The study aimed to investigate the antibody (Ab) production after SARS-Cov-2 infection and clarify the factors affecting the Ab generation in these pa...

Full description

Bibliographic Details
Main Authors: Huan Xie, Jing Zhang, Ran Luo, Yan Qi, Yizhang Lin, Changhao Han, Xi Li, Dongfeng Zeng
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Immunology
Subjects:
Lymphoma
COVID-19
SARS-CoV-2
Antibody
CD20
Online Access:https://doi.org/10.1186/s12865-024-00596-1

Internet

https://doi.org/10.1186/s12865-024-00596-1

Similar Items